FDA approves groundbreaking new pancreatic cancer drug

Дата публикации: 26-08-2026 21:20:41

The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer. 

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA approves landmark pancreatic cancer drug that's shown to improve survival	0	7.9	26-08-2026
2	FDA gives expedited approval to new groundbreaking pancreatic cancer drug	0	6.49	26-08-2026
3	Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival	0	7.13	04-06-2026
4	Promising new options for treating aggressive prostate cancer	7	8	18-10-2023
5	STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class	0	4.23	14-08-2026
6	Австралийские ученые нашли новый метод лечения агрессивной формы рака поджелудочной железы	0	0	05-08-2019
7	Más de 300 casos al año en Málaga: un nuevo fármaco arroja luz frente al cáncer de páncreas	2	6	12-07-2026
8	Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests	0	7.46	01-11-2020
9	FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma	0	9.18	22-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.77. Источник: www.myhighplains.com.